Article
Sensitization of cervical carcinoma cells to paclitaxel by an IPP5 active mutant.
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2014
Zeng Qi-Yan, Huang Yu, Zeng Lin-Jie, Huang Min, Huang Yong-Qi, Zhu Qi-Fang
Abstract excerpt
Paclitaxel is one of the best anticancer agents that has been isolated from plants, but its major disadvantage is its dose-limiting toxicity. In this study, we obtained evidence that the active mutant IPP5 (8-60hIPP5m), the latest member of the inhibitory molecules for protein phosphatase 1, sensitizes human cervix carcinoma cells HeLa more efficiently to the therapeutic effects of paclitaxel. The combination of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
